{"id":"doi:10.1056/nejmoa2505928","kind":"article","title":"Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes","authors":["Stephen James Nicholls","Imre J. Pavo","Deepak L. Bhatt","John B. Buse","Stefano Del Prato","Steven E. Kahn","Abraham Michael Lincoff","Darren K. McGuire","Debra Lee Miller","Michael Albrecht Nauck","Hiroshi Nishiyama","Steven E. Nissen","Naveed A. Sattar","Govinda J. Weerakkody","Russell J. Wiese","Bernard Zinman","Sophia Zoungas","Jan Basile","Melanie J Davies","Francesco Giorgino","Monika Kellerer","Linong Ji","Tamás T. Várkonyi","Venu Menon","Jonathan C. Broder"],"author_count":27,"year":2025,"published":"2025-12-17","venue":"New England Journal of Medicine","cited_by":220,"doi":"10.1056/nejmoa2505928","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2505928","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2505928","updated":null,"pmid":"41406444","pmcid":null,"openalex_id":"W4417497606","pdf_url":"http://publicatio.bibl.u-szeged.hu/38555/1/Varkonyi.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}